Changes

Jump to navigation Jump to search
no edit summary
The Food and Drug Administration Modernization Act of 1997 (FDAMA) ended the federal prohibition on marketing and promoting [[off-label]] uses of prescription drugs. This new law allowed limited marketing and promotion of off-label uses to certain audiences, including physicians, on the condition that the drug manufacturer had an application pending for FDA approval of the off-label use.

Drug manufacturers complained that did not go far enough in freeing restrictions on [[commercial speech]] with respect to their products.
Anthony, Irenaeus, Siteadmin, apieditor, Bureaucrats, Check users, nsAm_Govt_101RO, nsAm_Govt_101RW, nsAm_Govt_101_ta, nsJudgesRO, nsJudgesRW, nsJudges_talkRO, nsJudges_talkRW, nsTeam2RO, nsTeam2RW, nsTeam2_talkRO, nsTeam2_talkRW, oversight, Administrators
126,763

edits

Navigation menu